Država: Avstralija
Jezik: angleščina
Source: Department of Health (Therapeutic Goods Administration)
ondansetron hydrochloride dihydrate, Quantity: 4.99 mg (Equivalent: ondansetron, Qty 4 mg)
Accord Healthcare Pty Ltd
Injection, solution
Excipient Ingredients: citric acid monohydrate; sodium citrate dihydrate; sodium hydroxide; water for injections; hydrochloric acid; sodium chloride
Intramuscular, Intravenous
Pack of 1 pre-filled syringe
(S4) Prescription Only Medicine
Ondansetron injection is indicated ? For the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ? For the prevention and treatment of post-operative nausea and vomiting.
Visual Identification: Clear, colourless solution in an amber glass pre-filled syringe; Container Type: Syringe; Container Material: Glass Type I Coloured; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Registered
2020-11-09